Archives
-
EZ Cap™ Human p53 mRNA (ψUTP) Workflow
2026-09-29
Build a controlled, transient p53-expression assay with dose, delivery, and timing checkpoints using EZ Cap™ Human p53 mRNA (ψUTP). The workflow separates mRNA biology from carrier performance, helping researchers troubleshoot weak expression, toxicity, and discordant phenotypes.
-
D-N-Acetylgalactosamine: Workflow and QC Guide
2026-09-29
D-N-Acetylgalactosamine provides a defined, water-compatible source of N-acetyl-D-galactosamine for glycoprotein characterization and brain heteropolysaccharides analysis. It is suitable for aqueous or compatible DMSO workflows, but not ethanol-based preparations, and prepared solutions should not be retained for long-term storage.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-09-28
The PKH26 Red Fluorescent Cell Linker Kit supports stable red labeling of cell-membrane lipid regions for cell tracing and proliferation-oriented assays. It is intended for membrane labeling in vitro or in vivo, not for intracellular targets or non-membrane structures, and requires model-specific optimization and controls.
-
Bile Acid Subtypes Reveal CRC Immune-Prognostic Markers
2026-09-28
Feng et al. used transcriptomic subtyping to associate bile acid metabolism patterns with survival and immune features in colorectal cancer, highlighting CLCA1, UGT2A3, and ZG16 as candidate markers. The findings support further study of metabolic–immune relationships but do not yet establish these genes as treatment-selection biomarkers or prove that bile acid changes cause the observed immune states.
-
Protease Mapping Beyond the Active Site
2026-09-27
AEBSF.HCl can help translational researchers probe serine-protease contributions to APP processing and cell-lysis models. New necroptosis findings also offer a useful framework for distinguishing serine-protease activity from lysosomal cathepsin signaling—an important boundary for rigorous experimental interpretation.
-
Part-Coated CEC for α2-Receptor Binding Analysis
2026-09-26
This study introduces a part-coated open-tubular capillary electrochromatography method for estimating drug–α2-adrenergic receptor binding constants from changes in apparent mobility across columns with different receptor-coated lengths. It offers a way to reduce receptor consumption relative to approaches that vary soluble receptor concentration, while its results and computational comparisons support further evaluation for affinity screening.
-
SARS-CoV-2 N Protein Sequesters GADD34 mRNA
2026-09-25
Liu and colleagues report that SARS-CoV-2 nucleocapsid protein diverts GADD34 mRNA into atypical G3BP1-positive foci, reducing GADD34 expression and weakening IRF3-dependent interferon signaling. The study links stress-granule-like organization to a specific viral immune-evasion mechanism and identifies experimental questions for follow-up, while leaving the pathway’s scope across infection models to be established.
-
CMA Decline Drives Progressive Age-Related Myopathy
2026-09-25
This study identifies chaperone-mediated autophagy (CMA) as a regulator of skeletal-muscle integrity and links its age-related decline to altered mitochondrial proteins, impaired SERCA turnover, and disrupted calcium handling. Mouse and human findings, together with partial improvement after genetic CMA upregulation in old mice, position CMA as a relevant pathway for muscle-aging research while leaving its therapeutic potential to be tested.
-
Olsalazine Sodium: From Inflammation to Assay Design
2026-09-24
Olsalazine Sodium is a mesalamine dimer used to investigate inflammatory signaling and colorectal cancer models. This article examines how xenobiotic-clearance findings in mosquitoes can sharpen assay design—without confusing chemical disposition with therapeutic mechanism.
-
Solanesol (B8776): Practical Research Guide
2026-09-24
Solanesol (B8776) provides a defined, hydrophobic polyisoprenoid alcohol for membrane-related and biochemical research workflows where aqueous or ethanol-based handling is unsuitable. This guide covers DMSO preparation, storage, controls, and limitations; the compound is not intended for diagnostic or medical use.
-
Talin1–Piezo1–YAP Signaling in Atherosclerosis
2026-09-23
This study links disturbed-flow and inflammatory stimulation to a Piezo1–Ca²⁺–Talin1–YAP signaling sequence in endothelial cells, and identifies higher Talin1 levels in human CHD serum and atherosclerotic mouse models. Its combination of in vivo observations and endothelial-cell perturbation experiments supports Talin1 as a candidate regulator of vascular inflammation, while leaving important questions about causality and therapeutic relevance open.
-
CARDIO Reveals HSPB7 Rescue in Titin Cardiomyopathy
2026-09-23
Chopra and colleagues developed CARDIO, a high-content morphological profiling assay for human iPSC-derived cardiomyocytes, and used it to screen 39 cardiac-function-associated genes. The study identified HSPB7 loss as a modifier that restored contractile performance in titin-deficient cardiomyopathy models, while also showing that morphology-guided screening requires functional validation in engineered heart tissue.
-
Protein Corona Controls Nanoparticle Function
2026-09-22
Elizabeth Voke’s 2025 UC Berkeley dissertation develops a label-free proteomics workflow for identifying proteins that associate with lipid nanoparticles in human plasma. Its central finding is that greater cellular uptake does not necessarily produce greater mRNA expression, because corona proteins may redirect nanoparticles toward lysosomal trafficking.
-
Ginsenoside F1 Lipidomics in HepG2 Cells
2026-09-22
A 2026 study combined free fatty acid-induced HepG2 cell modeling with untargeted lipidomics to examine how ginsenoside F1 affects intracellular lipid disorders. The work identified glycerophospholipid and ether lipid metabolism as major response pathways, providing a mechanistic framework for evaluating botanical interventions in hyperlipidemia-related research.
-
Polybrene: Choosing the Right Delivery Context
2026-09-21
Polybrene, also known as Hexadimethrine Bromide, is more than a viral transduction additive. This guide connects its electrostatic mechanism, formulation constraints, and assay controls with practical lessons from modern targeted protein degradation research.